Skip to content

Released Feb 22, 2017, after the close

10-K filed Feb 22, 2017, 53 days after period end · 0001558370-17-000793

Q4 2016 · 10-K
Revenue$87.46M+64.1% vs Q4 2015+32.3% vs Q3 2016
Net Income-$13.51Mno prior Q4 2015 on fileN/M vs Q3 2016
EPS Diluted-$0.09N/M vs Q4 2015N/M vs Q3 2016
Operating Incomederived-$6,300,000N/M
Operating Cash Flowderived-$19,187,000N/M
Free Cash Flowderived-$20,385,000N/M
Margins · derived
Operating margin-7.2%+3.7 pt vs Q4 2015
Net margin-15.4%

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-K.

Same quarter

MetricQ4 2016Q4 2015Q4 2014Q4 2013
Revenue$87.46M$53.31M$38.07M$5.03M
Net Income-$13.51M———
EPS Diluted-$0.09-$0.09-$0.27-$0.43

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR